194 related articles for article (PubMed ID: 34223879)
1. A Simple Botulinum Toxin Injection Technique for Masseter Reduction.
Ng ZY; Yang T
Aesthet Surg J; 2021 Nov; 41(12):NP2104-NP2105. PubMed ID: 34223879
[No Abstract] [Full Text] [Related]
2. Ultrasound-Guided Botulinum Neurotoxin Injection for Masseter Hypertrophy Based on the Structural Pattern of Deep Inferior Tendon and Masseteric Contraction.
Wang YH; Chang SL; Hu S; Huang YL
Plast Reconstr Surg; 2022 Jul; 150(1):240e-242e. PubMed ID: 35767638
[No Abstract] [Full Text] [Related]
3. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin for masseter hypertrophy.
Fedorowicz Z; van Zuuren EJ; Schoones J
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin for masseter hypertrophy.
Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative analysis based on three-dimensional stereophotogrammetry in the observation of curative effect of botulinum toxin A on masseter hypertrophy].
Xue Z; Zeng W; Chen Z; Han Y
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):272-5. PubMed ID: 30044570
[TBL] [Abstract][Full Text] [Related]
7. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
[TBL] [Abstract][Full Text] [Related]
8. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
Aydil B; Başaran B; Unsaler S; Süoğlu Y
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
[TBL] [Abstract][Full Text] [Related]
10. RimabotulinumtoxinB versus OnabotulinumtoxinA in the treatment of masseter hypertrophy: a 24-week double-blind randomized split-face study.
Lee DH; Jin SP; Cho S; Feneran A; Youn CS; Won CH; Park GH; Kim BW; An J; Chang SE; Lee MW
Dermatology; 2013; 226(3):227-32. PubMed ID: 23774030
[TBL] [Abstract][Full Text] [Related]
11. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A injections for masticatory muscles hypertrophy: A systematic review.
Rauso R; Lo Giudice G; Tartaro G; Zerbinati N; Nicoletti GF; Fragola R
J Craniomaxillofac Surg; 2022 Jan; 50(1):7-18. PubMed ID: 34620536
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A in the management of masseter muscle hypertrophy.
Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional stereophotogrammetric method of quantifying the effect of botulinum toxin type A injections on masseter hypertrophy.
Adriaens J; van Loon B; Ingels KJ; Bergé SJ; Maal TJ
Plast Reconstr Surg; 2012 Aug; 130(2):376e-378e. PubMed ID: 22842446
[No Abstract] [Full Text] [Related]
15. Ultrasonographic Considerations for Safe and Efficient Botulinum Neurotoxin Injection in Masseteric Hypertrophy.
Lee HJ; Jung SJ; Kim ST; Kim HJ
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33406757
[TBL] [Abstract][Full Text] [Related]
16. Aesthetic uses of botulinum toxin A.
Niamtu J
J Oral Maxillofac Surg; 1999 Oct; 57(10):1228-33. PubMed ID: 10513870
[No Abstract] [Full Text] [Related]
17. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients.
Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB
J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570
[TBL] [Abstract][Full Text] [Related]
18. Duration of bite force reduction following a single injection of botulinum toxin in the masseter muscle bilaterally: A one-year non-randomized trial.
Ågren M; Nanchaipruek Y; Phumariyapong P; Apinuntham C; Rakchart S; Pettersson M; Wanitphakdeedecha R
J Oral Rehabil; 2023 May; 50(5):343-350. PubMed ID: 36810787
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for Botulinum Neurotoxin Injection for Facial Contouring.
Yi KH; Lee HJ; Hur HW; Seo KK; Kim HJ
Plast Reconstr Surg; 2022 Sep; 150(3):562e-571e. PubMed ID: 35759641
[TBL] [Abstract][Full Text] [Related]
20. Cervical lymphadenopathy following botulinum toxin type A injection for masseter hypertrophy: Is it just a coincidence?
Leng M; Zhao H
J Cosmet Dermatol; 2022 Oct; 21(10):5264-5265. PubMed ID: 35263487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
